BioNTech is a pioneering global biopharmaceutical company transforming medicine through innovative mRNA technologies. Founded on groundbreaking scientific research, we develop novel therapies for unmet medical needs across oncology, infectious diseases, and rare disorders. Our breakthrough COVID-19 vaccine demonstrates our commitment to rapid scientific response when facing global health challenges. With a diverse pipeline and strategic collaborations, BioNTech combines cutting-edge research, technological innovation, and manufacturing excellence to advance personalized treatments that harness the body's own mechanisms to fight disease. We're dedicated to improving patient outcomes worldwide through science-driven solutions.